ZENA ALADDIN: Open Payments
NPI 1336875988 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 17 payments from 10 companies in 2025. Trend: 2023 $195 · 2024 $276 · 2025 $381
Food & beverage: $381
| Company | Payments | Amount |
|---|---|---|
| Azurity Pharmaceuticals, Inc. | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Lilly USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $34 |
| Dexcom, Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: ALVESCO, MOUNJARO, AIRSUPRA, HORIZANT, SHINGRIX, Veozah, Dexcom G6 Transmitter, FARXIGA.
Industry payments across CA — which companies pay providers there.
